This new drug could break cancer’s resistance to treatment
60-Word AI Digest
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
Key Takeaways
- A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment.
- It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
- Full details and original dispatch available below.
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models.
Original Publisher Attribution
This summary was curated from ScienceDaily.